Day: December 10, 2023

SAN DIEGO -- Autologous stem-cell transplantation (ASCT) led to improved outcomes as compared with CAR T-cell therapy for patients with ...

SAN DIEGO -- A time-limited, targeted combination significantly improved survival compared with chemoimmunotherapy in fit chronic lymphocytic leukemia (CLL) patients ...

SAN DIEGO -- Administering emicizumab (Hemlibra) to previously untreated or minimally treated infants with severe hemophilia A without factor VIII ...

SAN ANTONIO -- The addition of inavolisib to palbociclib (Ibrance) plus fulvestrant (Faslodex) boosted progression-free survival (PFS) in patients with ...

SAN DIEGO — A newly approved gene therapy product for sickle cell disease, lovotibeglogene autotemcel (lovo-cel, marketed as Lyfgenia), led ...

SAN DIEGO — CD19-directed chimeric antigen receptor (CAR) T-cell therapy, which has transformed the treatment landscape for B-cell malignancies, is ...

SAN DIEGO -- A one-time treatment with lovotibeglogene autotemcel (Lyfgenia, lovo-cel) achieved near complete resolution of severe pain crises in ...

"You can't take the pot off the fire you can't turn down the heat." -- Josh Pickett, RN, a charge ...

SAN ANTONIO -- Combination therapy including a bispecific antibody targeting HER2 showed durable activity in patients with previously treated metastatic ...

Bade is a pulmonologist. Paul is a thoracic surgeon. Each year, we lose 127,000 Americans to lung cancer. That's nearly ...

SAN DIEGO -- Multiple myeloma patients in the clinic appear to benefit far less from standard treatments when compared with ...

SAN DIEGO -- An all-oral regimen for newly diagnosed acute promyelocytic leukemia (APL) proved "highly effective and safe," with most ...

Parkrun, which puts on free outdoor running events, tells BBC News they "usually see a strong upturn in January, particularly ...